MRI-guided Neurosurgical Ablation Market Key Insights:

The MRI-guided Neurosurgical Ablation Market size was valued at USD 412.08 million in 2023 and is expected to reach USD 654.69 million by 2032, growing at a CAGR of 5.28% over the forecast period of 2024-2032.

To Get More Information on MRI-guided Neurosurgical Ablation Market - Request Sample Report

The MRI-guided neurosurgical ablation market is growing rapidly owing to the increased demand for minimally invasive treatments, innovation in imaging technologies, and higher incidence of neurological disorders. MRI-guided systems provide excellent precision in targeting lesions within the brain that are deep in the brain and can be best used in treating conditions such as brain tumors, epilepsy, and Parkinson's disease. These technologies, like Medtronic's Visualase MRI-guided Laser Ablation System and Monteris Medical's NeuroBlate System, will revolutionize neurosurgical procedures by reducing the need for open surgery, leading to faster recovery times, less risk of infection, and improved outcomes for patients.

Technological innovations, including the integration of real-time imaging with laser ablation or focused ultrasound, are significantly enhancing the efficacy and accuracy of these systems. Companies like Insightec and Brainlab AG have introduced products that leverage MRI imaging for precise treatment of neurological conditions, contributing to their increasing adoption. In addition, the growing trend of outpatient procedures, driven by both technological advancements and healthcare cost considerations, is further accelerating market growth.

The rising incidence of neurological diseases, including epilepsy, brain tumors, and Parkinson's disease, is also driving demand for advanced neurosurgical treatments. According to the Global Burden of Disease (GBD) study, the burden of neurological conditions will nearly double by 2050. In addition, the aging population in developed regions worldwide will contribute to the market's growth because elderly people are more susceptible to neurological conditions. Moreover, research and clinical trials to expand the use of MRI-guided ablation techniques are opening new avenues for treating previously inoperable conditions.

Market Dynamics

Drivers

• Technological Advancement in MRI-guided Neurosurgical Ablation

More advanced MRI-guided neurosurgical ablation systems will drive the growth of the market. Improvements in MRI technology are enhancing the resolution of imaging and precision, thus making these procedures more effective and less invasive. For example, technologies such as Insightec's Exablate Prime and Monteris Medical's NeuroBlate with the NB3 FullFire 1.6mm laser probe are enhancing the accuracy and flexibility of treatments for neurological conditions such as epilepsy and brain tumors. These developments help in achieving improved patient results, shorter recovery periods, and fewer complications, which are essential factors in encouraging the use of MRI-guided neurosurgical ablation.

• Rising Incidence of Neurological Disorders and the Need for Minimally Invasive Procedures

The increasing incidence rate of neurological disorders, such as epilepsy glioblastoma, and other brain tumors, is fuelling the need for effective treatments like MRI-guided neurosurgical ablation. According to the Global Burden of Disease (GBD) study, more than 40% of the global population has a neurological condition. This is equivalent to 3.4 billion people. According to a report from the World Health Organization, over 50 million people across the world are affected with epilepsy. In response to this, many providers are moving towards minimally invasive treatments that offer high accuracy and reduce risks associated with an open surgical procedure.

For instance, treatments of epilepsy, which make up over 50% of MRI-guided ablation procedures, take advantage of the high precision of MRI systems to target specific areas of the brain, causing minimal damage to healthy tissue. Moreover, with the increased coverage of insurance policies for these procedures, access to them is further being promoted.

Restraint

• High Cost and Limited Access to MRI-guided Neurosurgical Ablation Systems

The cost-intensive nature of the technology is one significant restraint to the growth of the MRI-guided neurosurgical ablation market. Advanced MRI systems and related neurosurgical ablation equipment usually require huge investments, thus making it difficult for healthcare providers in low-resource settings to adopt such solutions. For example, the cost of an MRI-guided neurosurgical ablation system may be more than several million dollars, excluding the running operational and maintenance costs. Another complexity is the availability of skilled specialists to operate these systems. This high-cost limits access to these treatments in developing regions, where alternative, more cost-effective options are preferred.

A 2023 study revealed that 46% of the hospitals in low-income countries find it difficult to access MRI technology for neurosurgery. Meanwhile, only 10% of the hospitals can afford such an advanced MRI-guided neurosurgical system.

Segment Analysis

By Product

In 2023, the Accessories segment accounted for the largest share of 35% and is expected to witness the highest growth between 2024 and 2032. This growth is mainly due to the increased usage of accessories during neurosurgical procedures. Essential tools such as curettes, rongeurs, and dissectors are important for delicate surgeries like minimally invasive discectomies or opening skull bone windows. The accessories are designed to help neurosurgeons diagnose and restore the central nervous system with accuracy and safety.

The demand for quality functional accessories is on an upward rise as they become critical elements in achieving successful outcomes from neurosurgery. These would enhance maneuverability, precision, and the general functionality of neurosurgery, contributing directly to the expected increase in the MRI-guided neurosurgical ablation market in the following years.

By End Use

In 2023, Hospitals dominated the market with a market share of 63%. This dominance is attributed to the fact that hospitals typically house specialized neurosurgery departments equipped with advanced technology and staffed by highly skilled professionals. Due to their better ability to offer complete care and treatment, hospitals are usually the best locations for complex neurosurgeries like MRI-guided laser ablation for treating brain tumors or epilepsy. Therefore, during the forecasted period, demand for the use of MRI-guided neurosurgical ablation devices within hospitals will keep rising.

The Ambulatory Surgical Center (ASC) segment is expected to grow at the highest compound annual growth rate of 9% from 2024 to 2032. ASCs offer same-day surgeries and typically perform less invasive procedures, which lead to fewer complications and faster recovery times than traditional surgeries. ASCs are increasingly using MRI-guided neurosurgical ablation technologies for brain tumor treatments, where laser ablation surgeries require less invasive approaches and shorter recovery periods. Therefore, this segment is expected to grow the fastest because it can provide efficient, minimally invasive procedures with fewer complications.

Regional Analysis

In 2023, North America dominated the market with the largest share of MRI-guided neurosurgical ablation market, at 40%. This is primarily attributed to the region's already established healthcare infrastructure, the growth in the incidence of brain cancers and malignant tumors, and the availability of highly trained neurosurgeons. The increasing incidence of targeted diseases such as neurodegenerative disorders and brain tumors mainly fuels the growth in the MRI-guided neurosurgical ablation market. Major industry players like Medtronic, Boston Scientific Corporation, and Insightec Ltd. also strengthen the region's market. The number of minimally invasive neurosurgical procedures is on the rise, and neurological diseases are on the rise; hence, it fuels the market growth in North America.

The Asia Pacific region is expected to grow the fastest with a compound annual growth rate (CAGR) of 8% from 2024 to 2032. Contributing factors to this growth include a large patient population, increasing medical tourism, rising government healthcare spending, and a growing trend toward minimally invasive surgeries. In addition, the growth of intensive care units in hospitals and ambulatory surgical centers for the treatment of brain cancer, Alzheimer's disease, and other neurological disorders is driving the growth of the market in this region.

Do You Need any Customization Research on MRI-guided Neurosurgical Ablation Market - Inquire Now

Key Market Players

• Medtronic (Visualase MRI-guided Laser Ablation System, O-arm Surgical Imaging System)

• Monteris Medical (NeuroBlate System, AtamA Stabilization System)

• Brainlab AG (Curve Image-Guided Surgery, Elements Laser Navigation Software)

• Insightec (Exablate Neuro, Exablate 4000 Series)

• Boston Scientific Corporation (Vercise Deep Brain Stimulation Systems, iLab Ultrasound Imaging System)

• Elekta AB (Leksell Gamma Knife Icon, Elekta Neuromag)

• Zimmer Biomet (ROSA ONE Brain, ROSA Planning Software)

• Stryker Corporation (Stryker NAV3i Image-Guided System, Airo TruCT Mobile Imaging System)

• Philips Healthcare (Ingenia Ambition 1.5T MRI, SmartPath to dStream MRI Upgrades)

• Siemens Healthineers (MAGNETOM Vida 3T MRI, syngo.via Neurosuite)

• GE HealthCare (SIGNA Architect MRI System, Omni Legend PET/CT System)

• Synaptive Medical (Modus V Digital Microscope, BrightMatter Guide)

• Varian Medical Systems (Edge Radiosurgery System, TrueBeam Radiotherapy System)

• MedActa International (MySolutions Personal Alignment Technology, GMK Sphere for Neurological Applications)

• KARL STORZ GmbH & Co. KG (Image1 S 4K Rubina System, NAV1 ENT Surgical Navigation)

• Hitachi Medical Systems (Echelon Oval 1.5T MRI, Oasis High-Field Open MRI)

• Inomed Medizintechnik GmbH (C2 Nerve Monitor, NeuroExplorer Navigation System)

• Hyperfine (Swoop Portable MRI System, Neurovascular Imaging Software)

• ClearPoint Neuro, Inc. (ClearPoint Neuro Navigation System, SmartFrame Stereotactic Frame)

• Integra LifeSciences Corporation (Camino ICP Monitor, DuraGen Dural Graft Matrix)

Recent Developments

• May 2024, Monteris Medical- NeuroBlate NB3 FullFire 1.6mm Laser Probe- Monteris released the smallest commercially available laser probe for brain surgery, known as NeuroBlate NB3 FullFire 1.6mm. The latest product approved by the FDA in December 2023 allows precision in treating almost all brain lesions, be it a tumor or a focus for epilepsy. The more advanced cooling and laser technology enhance the precision and flexibility of laser ablation procedures for adult and pediatric patients. It promises to simplify the surgical process with a smaller device that minimizes the use of multiple tools.

• In February 2024, Anthem Blue Cross and Blue Shield (BCBS) introduced insurance coverage for the innovative focused ultrasound pallidotomy procedure. This decision is part of their broader efforts to enhance Parkinson’s disease treatment options under their comprehensive coverage plan.

• In 2024, with New Innovations in MRI-Guided Focused Ultrasound, Medtronic has been working on its MRI-guided Focused Ultrasound (MRgFUS) technology for neurosurgical ablation. Its advanced system will be even more precise and effective for the treatment of Parkinson's disease and essential tremor, using non-invasive surgery with the help of MRI guidance for enhanced treatment success.